Disintegration time failure during campaign changeover – root cause analysis breakdown


Published on 01/01/2026

Analysis of Disintegration Time Failures During Campaign Changeovers

In pharmaceutical manufacturing, particularly during the production of tablets, disintegration time is a critical quality parameter. A failure in achieving the specified disintegration time during a campaign changeover can signal underlying issues that may affect both product quality and patient safety. This article presents a structured investigation approach to address disintegration time failures, detailing symptoms, potential causes, immediate actions, investigation workflows, and robust corrective and preventive actions (CAPA).

By the end of this article, readers will acquire actionable insights into how to effectively manage disintegration time failures, ensuring compliance with Good Manufacturing Practices (GMP) and readiness for inspections by regulatory bodies such as the FDA, EMA, and MHRA.

Symptoms/Signals on the Floor or in the Lab

Disintegration failures can manifest in several ways, both on the production floor and in laboratory settings. Typical symptoms to watch for include:

  • Increased Disintegration Time: Products failing to meet the established disintegration time as specified in
the batch record.
  • Inconsistency: Variability in disintegration times between batches, indicating that consistent processes may have been disrupted.
  • Change in Appearance: Visual differences in tablet integrity post-manufacturing, such as cracks or surface abnormalities.
  • Customer Complaints: Reports from quality control or external customers regarding non-compliance with product specifications.
  • Recognizing these symptoms early enables timely investigations and mitigates risk to both product quality and regulatory compliance.

    Likely Causes

    Disintegration time failures can generally be categorized under the classic “5 Ms” framework: Materials, Method, Machine, Man, Measurement, and Environment. Below are potential causes by category:

    Category Likely Causes
    Materials Raw material quality variations (e.g., binders, excipients), changes in suppliers.
    Method Changes in the formulation, mixing times, or processing parameters during campaign changeovers.
    Machine Equipment malfunctions or inadequately cleaned and calibrated machinery.
    Man Lack of training or human error during transfer or manufacturing processes.
    Measurement Defects in measurement equipment or methods leading to inaccurate determinations of disintegration time.
    Environment Fluctuations in temperature, humidity, or other environmental conditions affecting tablet formation.

    Understanding these categories enables targeted investigation and rapid identification of potential root causes.

    Immediate Containment Actions (first 60 minutes)

    Upon identifying a disintegration time failure, immediate containment actions are essential to prevent further product distributions and ensure compliance:

    1. Isolate Affected Batches: Immediately quarantine affected batches and suspend production activities.
    2. Notification: Notify key stakeholders, including quality control and quality assurance departments, to prepare for comprehensive investigations.
    3. Evaluate and Record: Conduct a preliminary assessment of the situation, documenting all findings, including disintegration test results and any deviations from the established protocol.
    4. Conduct Initial Testing: Perform retesting of disintegration times on samples from the affected batch as well as historical data from prior successful batches.
    5. Review Current Operations: Examine the current operations and processes to identify any immediate discrepancies or deviations from protocols.

    These prompt actions will help contain the issue, minimize impact, and ensure all stakeholders are made aware for further investigation.

    Investigation Workflow

    A structured investigation workflow will provide clarity and focus, ensuring no step is overlooked. The following steps outline an effective approach to conducting the investigation:

    1. Define the Problem: Clearly articulate the nature of the disintegration failure, including when it occurred, batch numbers, and product details.
    2. Gather Data: Collect all relevant documentation, including batch records, equipment logs, and process parameters from the production run in question.
    3. Interview Personnel: Speak with operators and quality control personnel involved in the campaign changeover to gain insight into any changes or anomalies observed.
    4. Analyze the Data: Compare historical performance data and evaluate any trends or deviations that can indicate potential causal factors.
    5. Document Everything: Maintain thorough documentation throughout all stages of the investigation for regulatory compliance and traceability.

    The collective insights gained during the investigation should culminate in a detailed report that contributes to a comprehensive understanding of the disintegration failure.

    Root Cause Tools

    Identifying the root cause of a disintegration time failure involves employing various analytical tools. The three commonly used root cause analysis tools include:

    • 5-Why Analysis: This tool is effective for straightforward problems where the root cause can be discovered by repeatedly asking “why.” Typically used for more apparent issues where simplistic causative factors are involved.
    • Fishbone Diagram (Ishikawa): This is suitable for complex issues where multiple potential causes are involved across various categories (e.g., materials, methods, machines). It visually organizes possible causes into specific categories.
    • Fault Tree Analysis: This tool is helpful in more complex manufacturing environments and can model the failure events and their causes in a structured manner. It provides insights into combinations of failures leading to the disintegration issue.

    Choosing the appropriate tool requires assessing the complexity of the disintegration failure and the volume of contributing factors, ensuring effective identification of the root cause.

    CAPA Strategy

    Corrective and preventive actions (CAPA) should be comprehensive and actionable to address identified defects and prevent recurrence:

    1. Correction: Address any immediate issues with the affected batch by implementing necessary changes (e.g., formulation modifications, machine repairs).
    2. Corrective Action: Develop and execute actions to address the root causes identified during the investigation. This may include revising training programs or updating procedures and specifications.
    3. Preventive Action: Establish ongoing monitoring and procedural adjustments to prevent the identified root causes from returning, including implementing consistent quality checks during campaign changeovers.

    Documenting all actions, their implementation timelines, and their effectiveness is vital to ensure compliance and accountability.

    Control Strategy & Monitoring

    To ensure ongoing compliance with disintegration time standards, a robust control strategy should be enacted, including:

    • Statistical Process Control (SPC): Utilize SPC to monitor disintegration times on an ongoing basis and identify potential trends or deviations early.
    • Sampling Strategy: Implement a systematic sampling approach for each batch to verify disintegration times meet established specifications.
    • Alarms and Alerts: Employ process alarms to alert operators to any deviations from established parameters in real-time, allowing for prompt intervention.
    • Verification: Periodically verify the effectiveness of control measures and monitoring through routine audits and data analysis.

    Integrating these components into a comprehensive control strategy will support sustained product quality and compliance with regulatory expectations.

    Related Reads

    Validation / Re-qualification / Change Control Impact

    When addressing disintegration time failures, consideration should be given to validation, re-qualification, and change control processes. Key considerations include:

    • Validation: Ensure that any changes made to processes, materials, or equipment are appropriately validated to confirm their efficacy in maintaining disintegration time standards.
    • Re-qualification: After implementing corrective actions, re-qualification of manufacturing equipment may be necessary to ensure it performs as expected with the revised processes.
    • Change Control: Document any changes stemming from CAPA recommendations under change control procedures, ensuring all modifications are properly evaluated and approved.

    This layered approach ensures consistency in product quality and compliance with established regulatory expectations.

    Inspection Readiness: What Evidence to Show

    During regulatory inspections, having precise documentation and evidence available is crucial. Key records to present may include:

    • Batch Records: Ensure complete batch production records reflecting all process parameters, including any deviations or investigations related to disintegration times.
    • Deviation Reports: Thoroughly document any deviation investigations related to disintegration time failures, including root cause analyses and CAPA documentation.
    • Equipment Logs: Provide maintenance and calibration logs for machines used in the production of affected batches.
    • Quality Control Records: Present testing records verifying product quality, including historical data that supports trends in disintegration times.

    Maintaining detailed, well-organized records not only supports compliance but also demonstrates a commitment to quality assurance in the manufacturing process.

    FAQs

    What should be done first when a disintegration time failure is identified?

    The first priority should be to isolate the affected batch and notify relevant stakeholders. Immediate containment actions are also necessary to prevent any further distribution.

    How are root causes determined during an investigation?

    Root causes are determined by utilizing tools such as 5-Why Analysis, Fishbone Diagrams, and Fault Tree Analysis to systematically explore potential causes and validate them through data collection.

    What kind of documentation is necessary for regulatory inspections?

    Documentation should include batch records, deviation reports, quality control testing data, and equipment calibration logs, demonstrating thorough compliance with GMP practices.

    How often should monitoring of disintegration times occur?

    Monitoring should be ongoing, with statistical analysis used to verify disintegration times across batches, especially during and after campaign changeovers.

    What is the role of CAPA in addressing disintegration failures?

    CAPA involves implementing corrective and preventive actions to address the root cause of failures and ensure they do not recur in future batches.

    Can disintegration time failures affect a product’s market release?

    Yes, disintegration time failures can lead to a product being held for investigation and may delay market release, affecting supply chain timelines.

    How do environmental conditions impact disintegration time?

    Variations in temperature and humidity can significantly affect tablet formulation properties, thus influencing disintegration time during manufacturing and storage.

    What training is important for operators to prevent disintegration issues?

    Operators should receive comprehensive training on GMP practices, proper equipment operation, and awareness of the parameters affecting disintegration time.

    How often should equipment used in manufacturing be calibrated?

    Equipment should be calibrated regularly according to manufacturer’s recommendations and during any operational changes to ensure accuracy in measurement.

    What factors in material changes can influence disintegration times?

    Changes in suppliers, grades of excipients, or the introduction of new materials can all potentially impact the disintegration characteristics of the final product.

    When should a validation assessment for changes to the process be conducted?

    A validation assessment should be conducted whenever there are changes in processes, materials, or equipment that may impact product quality, including disintegration times.

    Pharma Tip:  Weight variation failure during campaign changeover – FDA inspection observation risk